|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of HLS Therapeutics (OTC: HLTRF) through any online brokerage.
There are no as such competitors for HLS Therapeutics.
The latest price target for HLS Therapeutics (OTC: HLTRF) was reported by Raymond James on August 6, 2021. The analyst firm set a price target for 0.00 expecting HLTRF to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for HLS Therapeutics (OTC: HLTRF) is $16.44 last updated Thu Oct 21 2021 17:05:21 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for HLS Therapeutics. The last dividend paid out to investors was $0.02 on October 23, 2018.
HLS Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for HLS Therapeutics.
HLS Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the OTC.